Trinity Biotech plc (TRIB)

NASDAQ: TRIB · IEX Real-Time Price · USD
3.198
+0.118 (3.83%)
Jul 19, 2024, 10:02 AM EDT - Market open
3.83%
Market Cap 23.17M
Revenue (ttm) 56.71M
Net Income (ttm) -21.53M
Shares Out 7.38M
EPS (ttm) 4.25
PE Ratio 0.69
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,205
Open 3.220
Previous Close 3.080
Day's Range 3.000 - 3.250
52-Week Range 1.490 - 5.250
Beta 1.31
Analysts n/a
Price Target n/a
Earnings Date May 23, 2024

About TRIB

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and o... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1992
Employees 380
Stock Exchange NASDAQ
Ticker Symbol TRIB
Full Company Profile

Financial Performance

In 2023, TRIB's revenue was $56.83 million, a decrease of -9.10% compared to the previous year's $62.52 million. Losses were -$24.02 million, -41.43% less than in 2022.

Financial Statements

News

Trinity Biotech Announces Appointment of A New CFO

DUBLIN, July 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...

9 days ago - GlobeNewsWire

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...

25 days ago - GlobeNewsWire

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, i...

5 weeks ago - GlobeNewsWire

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable...

6 weeks ago - GlobeNewsWire

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO 1 on annualized revenues of approximately $75 million by Q2 2025-

2 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Q1 2024 Financial Results

DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagno...

2 months ago - GlobeNewsWire

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

2 months ago - GlobeNewsWire

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

DUBLIN, Ireland, May 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

2 months ago - GlobeNewsWire

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

DUBLIN, Ireland, May 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

2 months ago - GlobeNewsWire

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, includi...

3 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical ...

4 months ago - GlobeNewsWire

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") ...

4 months ago - GlobeNewsWire

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American depos...

5 months ago - GlobeNewsWire

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) repre...

5 months ago - GlobeNewsWire

Trinity Biotech to Present at Emerging Growth Conference

DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present virtually at the Emerging Growth Conference on March...

5 months ago - GlobeNewsWire

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for ...

5 months ago - GlobeNewsWire

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company's results for the quarter ended September 30, 2023. Business Updates and Strategic Pri...

6 months ago - GlobeNewsWire

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch ...

6 months ago - GlobeNewsWire

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management

6 months ago - GlobeNewsWire

Trinity Biotech plc to Host Investor Call

Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET

6 months ago - GlobeNewsWire

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical la...

7 months ago - GlobeNewsWire

Trinity Biotech Announces Management Changes

John Gillard Named Chief Executive Officer Des Fitzgerald Named Interim Chief Financial Officer DUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a...

7 months ago - GlobeNewsWire

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Ireland, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical l...

8 months ago - GlobeNewsWire

Trinity Biotech Announces Q2 2023 Financial Results

DUBLIN, Ireland, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...

10 months ago - GlobeNewsWire

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will r...

10 months ago - GlobeNewsWire